Global Endoscopic Retrograde Cholangiopancreatography Devices Market Size By Type (Biliary Stone Removal Basket, Biliary Dilation Balloon), By Application (Liver, Gallbladder), By Region, And Segment...

The Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market was valued at USD 1.6 billion in 2023 and is projected to surpass USD 2.7 billion by 2031, expanding at a CAGR of 6.9% during the forecast period from 2023 to 2031. The increasing prevalence of gastrointestinal disorders, advancements in endoscopic technology, and the growing demand for minimally invasive procedures are primary factors driving the ERCP devices market. ERCP devices play a critical role in diagnosing and treating conditions related to the bile ducts, pancreatic ducts, and gallbladder, including gallstones, tumors, and strictures.

Drivers:

Rising Incidence of Gastrointestinal Disorders:

The growing prevalence of gastrointestinal and pancreatic diseases, including bile duct stones, pancreatic cancer, and biliary strictures, is propelling the demand for ERCP procedures globally.

Advancements in Endoscopic Technology:

Innovations such as high-definition imaging, single-use duodenoscopes, and enhanced visualization tools are improving diagnostic accuracy and patient outcomes, driving the adoption of ERCP devices.

Increasing Preference for Minimally Invasive Procedures:

The trend towards minimally invasive surgeries is gaining momentum due to shorter hospital stays, reduced surgical risks, and faster recovery, boosting the demand for ERCP devices.

Restraints:

High Cost of ERCP Procedures and Devices:

The significant cost associated with advanced ERCP devices, including single-use duodenoscopes, limits market growth, especially in developing regions.

Risk of Procedure-Related Infections:

Concerns regarding duodenoscope-associated infections and the need for stringent sterilization protocols can hinder the widespread adoption of reusable ERCP devices.

Opportunity:

Technological Innovation in Disposable ERCP Devices:

The increasing development and adoption of disposable and single-use ERCP devices to prevent cross-contamination offer lucrative growth opportunities for manufacturers.

Expansion in Emerging Markets:

Emerging economies in Asia-Pacific and Latin America present substantial growth potential due to rising healthcare expenditure, expanding medical infrastructure, and growing awareness of advanced endoscopic procedures.

Market by System Type Insights:

Based on system type, the ERCP Catheters & Guidewires segment held the largest market share in 2023. These devices are crucial for navigating complex ductal systems during ERCP procedures. Meanwhile, the Single-use Duodenoscope segment is anticipated to exhibit the highest growth rate during the forecast period, driven by increased demand for infection prevention and regulatory support for disposable devices.

Market by End-use Insights:

In terms of end-use, the Hospitals segment emerged as the largest revenue contributor in 2023, accounting for over 55% of the market share. The availability of advanced infrastructure, skilled professionals, and higher patient footfall make hospitals the primary end-users of ERCP devices. Ambulatory Surgical Centers (ASCs) are also witnessing increasing adoption due to cost-effective treatment and faster recovery times.

Market by Regional Insights:

Geographically, North America dominated the Global ERCP Devices Market in 2023, driven by well-established healthcare infrastructure, rising gastrointestinal disease prevalence, and early adoption of innovative devices. However, Asia-Pacific is poised to register the highest growth rate during the forecast period, supported by increasing healthcare investments, growing patient awareness, and the expanding presence of key market players.

Competitive Scenario:

Key players operating in the Global ERCP Devices Market include Boston Scientific Corporation, Olympus Corporation, Medtronic plc, CONMED Corporation, Cook Medical, Steris plc, Ambu A/S, Fujifilm Holdings Corporation, Becton, Dickinson and Company, and Taewoong Medical Co., Ltd. These companies focus on strategic acquisitions, product innovation, and geographical expansion to strengthen their market positions.

Key Market Developments:

In 2023, Boston Scientific Corporation launched a new line of single-use duodenoscopes aimed at minimizing cross-contamination risks and enhancing patient safety.

In 2024, Olympus Corporation expanded its ERCP product portfolio with advanced visualization and therapeutic devices to support complex endoscopic procedures.

In 2025, Medtronic announced a strategic partnership with a leading healthcare provider in Asia-Pacific to expand its distribution network for ERCP devices.

Scope of Work – Global Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices Market

Report Metric Details

Market Size (2023) USD 1.6 Billion

Projected Market Size (2031) USD 2.7 Billion

CAGR (2023-2031) 6.9%

Key Segments by System Type ERCP Catheters & Guidewires, Sphincterotomes, Biliary Stents, Single-use Duodenoscopes

Key Segments by End-use Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics

Leading Region North America

Key Players Boston Scientific Corporation, Olympus Corporation, Medtronic plc, Cook Medical, Ambu A/S

Market Drivers Rising gastrointestinal disorders, Technological advancements, Growing demand for minimally invasive procedures

Market Opportunities Adoption of disposable ERCP devices, Expansion in emerging markets

FAQs:

1. What is the current market size of the Global ERCP Devices Market?

The Global ERCP Devices Market was valued at USD 1.6 billion in 2023.

2. What is the major growth driver of the Global ERCP Devices Market?

The increasing prevalence of gastrointestinal disorders and technological advancements in endoscopic devices are the major growth drivers.

3. Which is the largest region during the forecast period in the Global ERCP Devices Market?

North America is the largest region in the Global ERCP Devices Market during the forecast period.

4. Which segment accounted for the largest market share in the Global ERCP Devices Market?

The ERCP Catheters & Guidewires segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global ERCP Devices Market?

Key players include Boston Scientific Corporation, Olympus Corporation, Medtronic plc, Cook Medical, and Ambu A/S.